So those are my two questions.

Okay.

Those are great questions, and I think they are very much coming from the way...

the state of things right now and the way that psychiatric illness has been treated by the sort of pharmaceutical industry, right? We've, we've come to accept this as a, a limitation that, you know, we're, we're gonna have this huge burden, and it's really hard.

But if you go to, let's say, neurology, which is, you know, where we're, we're next focusing our attention, nobody would ever say, you know, "The interventional radiologist has to do this crazy long surgery to remove your blood clot that caused you to have this stroke, but I'm sorry, occupational therapy is just too expensive.

You go on home." That would never happen, right? So in neurology, we have a totally different paradigm for understanding the importance of the learning combined with the intervention, and n- it's not a problem in neurology.

Nobody says in neurology, "How are we ever gonna pay for this intensive intervention and this intensive therapy? How are we ever gonna train enough occupational therapies to give people this, this medicine?" Right? So I, I'm hopeful that if we can demonstrate our theory, especially in, in the stroke trial that we are starting, hopefully within the next month, we can help, you know, establish this idea, this framework for understanding how psychedelics are working in neurology, where this is already accepted, and slowly bring psychiatry and psychological illnesses over to that way of thinking.

What else do you think needs to happen to actually change the cultural narrative?